Ran Frenkel
Corporate Officer/Principal chez 2P2D Solutions Ltd.
Profil
Ran Frenkel is the founder of Pfc Pharma Focus Israel Ltd.
which was founded in 2007.
He is currently the Vice President-Business Development at 2P2D Solutions Ltd.
Mr. Frenkel's former positions include Managing Director-EMEA at Clinipace, Inc. from 2011 to 2013, Managing Director at Actelion Pharmaceuticals US, Inc. from 2004 to 2007, and Executive VP-Worldwide Development Operations at Karyopharm Therapeutics, Inc. from 2014 to 2015.
Mr. Frenkel received his undergraduate degree from The Hebrew University of Jerusalem in 1993.
Postes actifs de Ran Frenkel
| Sociétés | Poste | Début |
|---|---|---|
2P2D Solutions Ltd.
 2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | 08/03/2011 |
Anciens postes connus de Ran Frenkel
| Sociétés | Poste | Fin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 27/07/2022 |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/01/2013 |
| Pfc Pharma Focus Israel Ltd. | Fondateur | 01/01/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2007 |
Formation de Ran Frenkel
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Commercial Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Health Technology |
2P2D Solutions Ltd.
2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Pfc Pharma Focus Israel Ltd. |
